LexBlog IP

DECEMBER 12, 2023

3] Synthetic data has many practical use cases already, including in the insurance sector, medical research,[4] or drug discovery and testing.[5] And Part 4 will explore other key legal topics to be considered when using synthetic data to train an AI model. [1] 1] Some of the most prominent cases currently pending in U.S.

IP 52

IP Database Right Intellectual Property Copyright 52

LexBlog IP

SEPTEMBER 9, 2022

The second portion of the notice emphasizes the consistency of disclosure to the USPTO among other governmental agencies and commercialization activities, including market testing, offers for sale, and reduction to practice. Director Vidal highlights four different topics as they relate to the duty of disclosure standard: 1.

Government 52

Government Intellectual Property Marketing Marketing 52

43(B)log

MARCH 25, 2024

Food & Drug Admin., What about the argument that the images might be subject to several different interpretations, and the FDA didn’t test for consumer takeaway? “[W]hen The FDA even tested their effectiveness in raising consumer awareness and then refined them based on those results. R J Reynolds Tobacco Co.

Advertising 64

Advertising Advertising Social Media Government 64

The IPKat

DECEMBER 29, 2022

The latter has held the position for four years and writes: " The students that select this module often have very specific reasons, they have their own app, they post their music online, they have a start-up idea, they want to fight counterfeit drugs or understand the value of luxury brands or the IP related risks on social media platforms.

Non-Fungible Tokens 67

Non-Fungible Tokens Intellectual Property Management Social Media Intellectual Property 67

Technology & Marketing Law Blog

JANUARY 9, 2024

Snap workaround of claiming to sue over Snap’s first-party product design choices, not the drug dealers’ content: Plaintiffs disavow any claim based upon Snap’s activities as a publisher of the third-party (drug seller) content. ”) as a defective product. As indicated by Doe II v.

Publishing 74

Publishing Designs Design Law 74

The IPKat

FEBRUARY 24, 2023

The European patent attorney community is currently eagerly awaiting the decision of the Enlarged Board of Appeal referral G 2/21 on the thorny topic of plausibility and post-filed evidence. Establishing the plausibility of an invention is often considered a higher bar than the standard sufficiency test.

Invention 131

Invention Law Patent Publishing 131

LexBlog IP

OCTOBER 19, 2023

Manufacturing : Manufacturing and product quality challenges and opportunities for individualized CGTs in light of, for example, small batch sizes, tailoring of batches to individual patients, and need for rapid testing and release. For many individualized CGT products, each batch is tailored to an individual patient (e.g.,

Editing 52

Editing Designs Design Technology 52

43(B)log

NOVEMBER 9, 2023

Gust allegedly “developed an outpatient treatment model based on the principle of addiction as a pathological relationship to intoxication rather than as a preference [for] a specific drug.” If you remove the drug—the individual who is still addicted to intoxication will find another way to get high.

False Advertising 64

False Advertising Advertising Advertising Copying 64

SpicyIP

JULY 21, 2021

The Delhi Court in an order dated 20 July 2021 vacated an ex-parte interim injunction ( pdf ), allowing the defendant to export the patented drug for R&D purposes on the condition that it files an affidavit mentioning the quantities of the drug exported and undertaking that the export is only for the above said purpose.

Patent 98

Patent Advertising Advertising Law 98

SpicyIP

JULY 11, 2021

Topical Highlight. I analysed Bajaj Healthcare’s application for compulsory license to manufacture Eli Lilly’s Baricitinib, an arthritis drug more recently used for Covid treatment. IPAB Issue Finally Comes to a Conclusion: Delhi HC Creates Specialist IP Division. News from around the World.

Moral Rights 105

Moral Rights Journalism Licensing IP 105

SpicyIP

JULY 26, 2021

Topical Highlight. In this post , Praharsh discussed the recent Delhi High Court order vacating an ex-parte interim injunction, allowing the SMS Pharmaceuticals to export Merck’s patented anti-diabetic drug ‘Sitagliptin’ for R&D purposes. Thematic Highlight. Pesticide Patents: Not ‘Working’ Out?

Copyright 97

Copyright Patent Television Intellectual Property 97

U.S. Department of Commerce

OCTOBER 10, 2022

While it may seem there is a special day for everything on our modern calendar, perhaps having a small nudge gives us an opportunity to think deeper about important topics and people that are a part of our life. Overuse of substances like alcohol or drugs. This represents 1 in 20 adults. million people). Thinking about suicide.

82

82

SpicyIP

FEBRUARY 12, 2024

Last week we published 9 posts on topics such as our comments on the proposed Trademarks (1st Amendment) Rules, the Madras High Court’s decision with respect to patentability of business methods, and Union Minister of State for Commerce’s response on ability of the current IPR regime to cater concerns arising out of AI generated work.

Trademark 103

Trademark Social Media Registering Trademarks Copyright 103

SpicyIP

FEBRUARY 5, 2024

Last week we published 9 posts on topics such as the Patent (2 nd Amendment) Rules, the Delhi High Court-Butter Chicken Controversy, and developments regarding the public search and e-register feature of the TMR website. Unfortunately, the issue of similar brand names for different drugs treating different ailments is pretty common in India.

Trademark 59

Trademark Settlement Licensing Copyright Infringement 59

SpicyIP

DECEMBER 30, 2023

As in previous years, we have divided these developments into five categories: a) Top 10 IP Judgements/Orders (Topicality/Impact) b) Top 10 IP Judgements/Orders (Jurisprudence/Legal Lucidity) c) Top 10 IP Legislative and Policy Related Developments d) Other IP Developments; and e) Other Notable Developments. RDB and Co. Hari Shankar.

IP 124

IP Copyright Trademark Intellectual Property 124

SpicyIP

JULY 19, 2021

Topical Highlight. The National Pharmaceutical Pricing Authority (NPPA) has invoked the terms of paragraph 19 of the Drugs Prices Control Order (DPCO) – 2013 to cap the price of five medical devices: a pulse oximeter, a blood pressure monitoring machine, a nebulizer, a digital thermometer, and a glucometer. News from India.

Advertising 105

Advertising Advertising Non-Fungible Tokens Intellectual Property 105

SpicyIP

AUGUST 30, 2021

Topical Highlight. They also stressed that since the company had stocked up a large amount of the goods under consideration and since these were medicinal supplies, which on an average, had an expiration period of just one year, they should be allowed to make their drugs available for commercial supply in the market. Sun Pharma v.

Non-Fungible Tokens 105

Non-Fungible Tokens Fair Use Advertising Advertising 105

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

But more launches are likely to come as new biosimilars complete clinical testing and FDA review and are approved. Biosimilar Drug. BI had asked FDA to change its interpretation of the term “strength” as used in the BPCIA for parenteral solutions to mean “total drug content” without regard to concentration. Reference Product.

Litigation 52

Litigation Settlement Patent Marketing 52

LexBlog IP

DECEMBER 31, 2022

In the intellectual property (IP) space, there has been explosive growth in this area, with AI-based patent filings addressing trending areas, including disease identification and diagnosis, drug discovery, personalized medicine, and clinical trials, among others. Drug Discovery and Manufacture. Preventing heart problems.

Intellectual Property 52

Intellectual Property IP Technology Privacy 52